KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 13 years of Other Working Capital Changes data on record, last reported at -$193.2 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 1251.09% year-over-year to -$193.2 million; the TTM value through Dec 2025 reached -$69.7 million, up 55.53%, while the annual FY2025 figure was -$69.7 million, 55.53% up from the prior year.
  • Other Working Capital Changes reached -$193.2 million in Q4 2025 per IONS's latest filing, down from $158.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $158.0 million in Q3 2025 and bottomed at -$193.2 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is -$17.3 million, with a median of -$12.8 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: plummeted 10979.43% in 2024, then skyrocketed 204.0% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$11.2 million in 2021, then crashed by 543.87% to -$72.2 million in 2022, then soared by 121.37% to $15.4 million in 2023, then tumbled by 192.64% to -$14.3 million in 2024, then crashed by 1251.09% to -$193.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$193.2 million in Q4 2025, $158.0 million in Q3 2025, and -$46.9 million in Q2 2025.